A First in Human, Dose Escalation Study to Evaluate the Safety and Tolerability of BBP-671 in Healthy Volunteers and Patients With Propionic Acidemia or Methylmalonic Acidemia

Clinical trial NCT04836494 · TERMINATED

Trial details

NCT number: NCT04836494
Sponsor: CoA Therapeutics, Inc., a BridgeBio company
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers Propionic Acidemia Methylmalonic Acidemia Organic Acidemia

Start date: 2021-03-25
Primary completion: 2023-11-20
Enrollment: 79

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.